Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00921661 | Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer | PHASE1 | COMPLETED | 16 | — | — | Jun 1, 2009 | Jun 1, 2012 | Nov 9, 2012 | 1 | Japan |
| Arm | Type | Description |
|---|---|---|
| AVE0005 (aflibercept) | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| AVE0005 (aflibercept) | DRUG | IV infusion |
Inclusion Criteria: * Patients with histologically or cytologically proven malignant tumor of the colon or rectum which is metastatic and inoperable. * Patients must have received at least one prior line of treatment with any standard of care, who have failed the treatment, or who have not been eli...